The purpose of this review is to describe the recent advances in identifying possible factors involved in the pathogenesis of spasmodic dysphonia. Spasmodic dysphonia is a task-specific focal laryngeal dystonia characterized by irregular and uncontrolled voice breaks. Pathogenesis of the disorder is poorly understood.
Data Sources
PubMed, Google Scholar, and Cochrane Library.
Review Methods
The data sources were searched using the following search terms: (spasmodic dysphonia or laryngeal dystonia) and (etiology, aetiology, diagnosis, pathogenesis, or pathophysiology).
Conclusions
Several potential etiological factors have been proposed by epidemiological, genetic, and neuropathological studies. Spasmodic dysphonia is a rare disorder primarily affecting females beginning in their 40s. Vocal tremor co-occurs in 30% to 60%. Large cohort studies identified risk factors such as a family history of neurological disorders including dystonia and tremor, recent viral illness, and heavy voice use. As none are rare events, a complex interactive process may contribute to pathogenesis in a small proportion of those at risk. Consequences to pathogenesis are neurological processes found in spasmodic dysphonia: loss of cortical inhibition, sensory processing disturbances, and neuroanatomical and physiological differences in the laryngeal motor control system.
Implications for Practice
Diagnosis of spasmodic dysphonia usually includes speech and laryngoscopic assessment. However, as diagnosis is sometimes problematic, measurement of neurophysiological abnormalities may contribute useful adjuncts for the diagnosis of spasmodic dysphonia in the future.
Castelon KonkiewitzETrender-GerhardIKammCet al. Service-based survey of dystonia in munich. Neuroepidemiology. 2002;21:202-206.
5.
RobeEBrumlikJMooreP. A study of spastic dysphonia: neurologic and electroencephalographic abnormalities. Laryngoscope. 1960;70:219-245.
6.
DedoHH. Recurrent laryngeal nerve section for spastic dysphonia. Ann Otol Rhinol Laryngol. 1976;85:451-459.
7.
TannerKRoyNMerrillRMSauderCHoutzDRSmithME. Case-control study of risk factors for spasmodic dysphonia: a comparison with other voice disorders. Laryngoscope. 2012;122:1082-1092.
8.
BlitzerALovelaceREBrinMFFahnSFinkME. Electromyographic findings in focal laryngeal dystonia (spastic dysphonia). Ann Otol Rhinol Laryngol. 1985;94:591-594.
9.
LudlowCLNauntonRFSedorySESchulzGMHallettM. Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia. Neurology. 1988;38:1220-1225.
10.
AdlerCHBansbergSFKrein-JonesKHentzJG. Safety and efficacy of botulinum toxin type B (Myobloc) in adductor spasmodic dysphonia. Mov Disord. 2004;19:1075-1079.
11.
AdamsSGDurkinLCIrishJCWongDLHuntEJ. Effects of botulinum toxin type A injections on aerodynamic measures of spasmodic dysphonia. Laryngoscope. 1996;106:296-300.
12.
MorNSimonyanKBlitzerA. Central voice production and pathophysiology of spasmodic dysphonia [published online May23, 2017]. Laryngoscope.
13.
AliSOThomassenMSchulzGMet al. Alterations in CNS activity induced by botulinum toxin treatment in spasmodic dysphonia: an H215O PET study. J Speech Lang Hear Res. 2006;49:1127-1146.
14.
BielamowiczSLudlowCL. Effects of botulinum toxin on pathophysiology in spasmodic dysphonia. Ann Otol Rhinol Laryngol. 2000;109:194-203.
15.
LudlowCLAdlerCHBerkeGSet al. Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg. 2008;139:495-505.
16.
IzdebskiKDedoHHBolesL. Spastic dysphonia: a patient profile of 200 cases. Am J Otolaryngol. 1984;5:7-14.
17.
TannerK. Epidemiologic advances in spasmodic dysphonia. SIG 3 Perspect Voice Voice Disord. 2012;22:104-111.
18.
BlitzerAJahnAFKeidarA. Semon’s law revisited: an electromyographic analysis of laryngeal synkinesis. Ann Otol Rhinol Laryngol. 1996;105:764-769.
19.
ChildsLRickertSMurryTBlitzerASulicaL. Patient perceptions of factors leading to spasmodic dysphonia: a combined clinical experience of 350 patients. Laryngoscope. 2011;121:2195-2198.
20.
PatelABBansbergSFAdlerCHLottDGCrujidoL. The Mayo Clinic Arizona spasmodic dysphonia experience: a demographic analysis of 718 patients. Ann Otol Rhinol Laryngol. 2015;124:859-863.
21.
de GusmaoCMFuchsTMosesAet al. Dystonia-causing mutations as a contribution to the etiology of spasmodic dysphonia. Otolaryngol Head Neck Surg. 2016;155:624-628.
22.
BlitzerA. Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series. Eur J Neurol. 2010;17(suppl 1):28-30.
23.
PayneSTischSColeIBrakeHRoughJDarvenizaP. The clinical spectrum of laryngeal dystonia includes dystonic cough: observations of a large series. Mov Disord. 2014;29:729-735.
24.
Kiese-HimmelCZwirnerP. Psychological factors in spasmodic dysphonia [in German]. Laryngorhinootologie. 1996;75:397-402.
25.
DauerWTBurkeREGreenePFahnS. Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia. Brain. 1998;121:547-560.
26.
BalintBBhatiaKP. Dystonia: an update on phenomenology, classification, pathogenesis and treatment. Curr Opin Neurol. 2014;27:468-476.
27.
LohmannKWilcoxRAWinklerSet al. Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene. Ann Neurol. 2013;73:537-545.
28.
SimonsCWolfNIMcNeilNet al. A de novo mutation in the beta-tubulin gene TUBB4A results in the leukoencephalopathy hypomyelination with atrophy of the basal ganglia and cerebellum. Am J Hum Genet. 2013;92:767-773.
29.
FuchsTGavariniSSaunders-PullmanRet al. Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia. Nat Genet. 2009;41:286-288.
30.
SkogseidIM. Dystonia—new advances in classification, genetics, pathophysiology and treatment. Acta Neurol Scand Suppl. 2014;(198):13-19.
31.
SegawaMNomuraY. Genetics and pathophysiology of primary dystonia with special emphasis on DYT1 and DYT5. Semin Neurol. 2014;34:306-311.
32.
DjarmatiASchneiderSALohmannKet al. Mutations in THAP1 (DYT6) and generalised dystonia with prominent spasmodic dysphonia: a genetic screening study. Lancet Neurol. 2009;8:447-452.
JinnahHABerardelliAComellaCet al. The focal dystonias: current views and challenges for future research. Mov Disord. 2013;28:926-943.
35.
DeLongMRWichmannT. Circuits and circuit disorders of the basal ganglia. Arch Neurol. 2007;64:20-24.
36.
PollackAE. Anatomy, physiology, and pharmacology of the basal ganglia. Neurol Clin. 2001;19:523-534.
37.
BolognaMPaparellaGFabbriniAet al. Effects of cerebellar theta-burst stimulation on arm and neck movement kinematics in patients with focal dystonia. Clin Neurophysiol. 2016;127:3472-3479.
38.
SamargiaSSchmidtRKimberleyTJ. Cortical silent period reveals differences between adductor spasmodic dysphonia and muscle tension dysphonia. Neurorehabil Neural Repair. 2016;30:221-232.
39.
CakmurRDonmezBUzunelFAydinHKeskenS. Evidence of widespread impairment of motor cortical inhibition in focal dystonia: a transcranial magnetic stimulation study in patients with blepharospasm and cervical dystonia. Adv Neurol. 2004;94:37-44.
40.
LanzaroMPetroneRD’AmbrosioA. Successful treatment with clozapine in a patient with neuroleptic-induced acute laryngeal dystonia. Eur Psychiatry. 2001;16:261-262.
41.
KirkeDNFruchtSJSimonyanK. Alcohol responsiveness in laryngeal dystonia: a survey study. J Neurol. 2015;262:1548-1556.
42.
PapapetropoulosSLundyDSCasianoRRSingerC. Laryngeal dystonia as a presenting symptom of young-onset Parkinson’s disease. Mov Disord. 2007;22:1670-1671.
43.
GaneshMJabbarUIskanderFH. Acute laryngeal dystonia with novel antipsychotics: a case report and review of literature. J Clin Psychopharmacol. 2015;35:613-615.
44.
SimonyanKBermanBDHerscovitchPHallettM. Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia. J Neurosci. 2013;33:14705-14714.
45.
TermsarasabPRamdhaniRABattistellaGet al. Neural correlates of abnormal sensory discrimination in laryngeal dystonia. Neuroimage Clin. 2016;10:18-26.
46.
AntelmiEErroRRocchiLet al. Neurophysiological correlates of abnormal somatosensory temporal discrimination in dystonia. Mov Disord. 2017;32:141-148.
47.
HammerMJBarlowSM. Laryngeal somatosensory deficits in Parkinson’s disease: implications for speech respiratory and phonatory control. Exp Brain Res. 2010;201:401-409.
48.
Bara-JimenezWSheltonPHallettM. Spatial discrimination is abnormal in focal hand dystonia. Neurology. 2000;55:1869-1873.
49.
LudlowCLSchulzGMYamashitaTDeleyiannisFW. Abnormalities in long latency responses to superior laryngeal nerve stimulation in adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol. 1995;104:928-935.
50.
DeleyiannisFWGillespieMBielamowiczSYamashitaTLudlowCL. Laryngeal long latency response conditioning in abductor spasmodic dysphonia. Ann Otol Rhinol Laryngol. 1999;108:612-619.
51.
SimonyanKLudlowCL. Abnormal activation of the primary somatosensory cortex in spasmodic dysphonia: an fMRI study. Cereb Cortex. 2010;20:2749-2759.
52.
WaughJLKusterJKLevensteinJMet al. Thalamic volume is reduced in cervical and laryngeal dystonias. PLoS One. 2016;11:e0155302.
53.
SimonyanKTovar-MollFOstuniJet al. Focal white matter changes in spasmodic dysphonia: a combined diffusion tensor imaging and neuropathological study. Brain. 2008;131:447-459.
